A Wisconsin stem cell clinic has been cautioned by the FDA for marketing intrathecal and intravenous injections of human stem cell and tissue-based products for a variety of neurologic conditions, according to the Regulatory Affairs Professionals Society.
Biologics
Orthobiologic company Biologica Technologies on Oct. 6 launched OsseoGen, a cellular bone matrix designed for bone regeneration.
Regenerative medicine company Aziyo Biologics on Sept. 28 appointed Matthew Ferguson as CFO.
Regenerative medicine company Histogen has received a $2 million grant to help fund a clinical trial for knee cartilage regeneration.
Richmond, Va.-based VCU Health spine surgeon Rick Placide, MD, implanted the first Signafuse strips in a patient during a posterolateral lumbar fusion, according to a Sept. 2 news release.
Advertisement
A number of emerging biologic technologies are currently being evaluated and launched in the spine field. Here are six key developments in the past month:
Orthobiologics company Kuros Biosciences has treated the first patient in its clinical trial evaluating Fibrin-PTH for transforaminal lumbar interbody fusion in patients with degenerative disc disease.
Orthobiologics company Royal Biologics acquired the Fibrinet system from Vertical Spine Sept. 1.
Biopharmaceutical company DiscGenics has raised $50 million in a Series C funding round, according to an Aug. 25 news release.
The Steadman Philippon Research Institute in Vail, Colo., has received a grant from the National Institutes of Health to study the use of bone marrow stem cells to delay osteoarthritis in the knee.